Press Releases
Keyword Search
03.25.24
OpGen Announces Acquisition of Preferred Stock by David Lazar
11.14.23
OpGen Reports Third Quarter 2023 Financial Results and Provides Business Update
10.12.23
OpGen Enters Into Warrant Inducement Transaction for up to $11.2 Million in Gross Proceeds
08.10.23
OpGen Reports Second Quarter 2023 Financial Results and Provides Business Update
08.07.23
OpGen’s Subsidiary Ares Genetics Releases New Features to its AREScloud Offering
08.03.23
OpGen’s Subsidiary Curetis and FIND Extend R&D Collaboration Agreement
08.03.23
OpGen to Provide Business Update and Financial Results for the Second Quarter 2023 on August 10th at 4:30 p.m. Eastern Time
07.19.23
OpGen’s Subsidiary Curetis Meets Milestones of Extended and Expanded R&D Collaboration with FIND
06.26.23
OpGen Subsidiary Ares Genetics Successfully Maintains Key Patent under Opposition in Europe
06.22.23
OpGen’s Subsidiary Curetis Receives Batch of Ten New C-Series Unyvero A30 Instruments